Shopping Cart 0
Cart Subtotal
AED 0

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 7322

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 14643

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 21965

Details

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-India

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-India". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of India. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The Indian pharmaceutical market was valued at USD 19.8B in 2010 and increased to USD 27.6B in 2016 at a Compound Annual Growth Rate (CAGR) of 5.6%. Its value was forecast to be USD 30.8B in 2018 and expected to reach USD 38.3B by 2022. The medical devices industry was valued at USD 18.9B in 2018 and is forecast to increase to USD 25.4B in 2022. India offers affordable medical services which has resulted in a rise in the country's medical tourism market. In 2016, 427,014 medical visas were issued by India. This was 4.85% of the total visas issued by India that year. India has also emerged as a hub for R&D activities for international players due to its cost-effective clinical research.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the India, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sun Pharma, Biocon, Lupin, Cipla and Zydus Cadila) and profiles and SWOT analyses of the major players in the medical device market (Roche Diagnostics, DePuy Synthes, Abbott and Allengers)

- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of India

- Porter's five forces analysis for pharmaceutical and medical devices market of India

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Indian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Indian healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Indian healthcare market.

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Overview

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

India, Pharmaceutical Market,Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape,Deals, Porter Five Forces, Opportunities and Challenges

Company Profile

Company Profile Title

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-India

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-India". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of India. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The Indian pharmaceutical market was valued at USD 19.8B in 2010 and increased to USD 27.6B in 2016 at a Compound Annual Growth Rate (CAGR) of 5.6%. Its value was forecast to be USD 30.8B in 2018 and expected to reach USD 38.3B by 2022. The medical devices industry was valued at USD 18.9B in 2018 and is forecast to increase to USD 25.4B in 2022. India offers affordable medical services which has resulted in a rise in the country's medical tourism market. In 2016, 427,014 medical visas were issued by India. This was 4.85% of the total visas issued by India that year. India has also emerged as a hub for R&D activities for international players due to its cost-effective clinical research.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the India, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sun Pharma, Biocon, Lupin, Cipla and Zydus Cadila) and profiles and SWOT analyses of the major players in the medical device market (Roche Diagnostics, DePuy Synthes, Abbott and Allengers)

- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of India

- Porter's five forces analysis for pharmaceutical and medical devices market of India

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Indian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Indian healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Indian healthcare market.

READ MORE

Scope

Table of Contents

Executive Summary

Overview

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

India, Pharmaceutical Market,Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape,Deals, Porter Five Forces, Opportunities and Challenges